Medical imaging AI & teleradiology · Radiology
Eden
A cloud based Diagnostic OS built in Mexico City to make radiology reports faster and more consistent across Latin America. The company says its platform now touches thousands of clinics and hospitals; the AI features layered on top of it are still mostly company described, not independently measured.
A bra, then a booth, then a platform
Eden did not start as a software company. It started as a wearable. In 2016, teenagers in Monterrey led by Julian Rios Cantu built a bra lined with temperature, texture and color sensors, meant to flag possible breast tumors through changes in skin heat. They called the company Higia Technologies and the product Eva. Rios Cantu had watched his mother go through cancer treatment three times, and he filed a US patent for what the filing calls an intelligent brassiere for breast health diagnosis and monitoring.
The bra could not be manufactured cheaply at scale, so the team pivoted to a network of diagnostic booths running thermal imaging scans with results in about ten minutes. By 2020 there were 15 across Mexico. Then the pandemic closed in person appointments, and the booths closed with them.
What survived was the underlying problem: too few radiologists, reading too many images, on software built for a different market. Starting in August 2021, the team rebuilt the company around that problem, digitizing radiology workflows instead of screening breasts directly. The rebrand to Eden followed.
The gap it is aimed at
Mexico trains radiologists slowly and unevenly. In a 2022 interview, Rios Cantu put the number at about 7,500 radiologists for a population of 120 million, worse outside the big cities. In a 2023 interview he cited a lower figure, about 4,500. Both numbers are his own, gathered years apart, with no published methodology behind either count.
Eden's answer is a cloud based picture archiving and communication system, the software radiologists use to view, analyze and report on medical images, sold as a subscription instead of a capital purchase. On top of it sit AI features called Eden Creator and Eden AI, aimed at automating parts of the reporting process and flagging findings for review. The pitch to a clinic is lower infrastructure cost; the pitch to a radiologist is fewer repetitive tasks.
Founders
Julian Rios Cantu is the constant across both eras of the company. He was 16 when he recruited classmates to build the Eva bra, and by 18 he had won the Global Student Entrepreneur Award, the youngest winner at the time. Higia Technologies was named one of Forbes Mexico's 30 most promising businesses in 2018, the same year the company went through Y Combinator's Summer batch. Mexico's presidency awarded him the Sol Azteca national medal for technology and innovation. He now lists Palo Alto, California as his base, alongside Eden's Mexico City headquarters.
Two other names recur in the record. Antonio Torres is named as a Higia co-founder by Dealroom and appears as a director on Eden's earliest and 2022 SEC filings. Raymundo Gonzalez Leal, described in a 2024 release as Rios Cantu's co-founder, appears as a director on the 2024 filing. Y Combinator's company page lists a second active founder titled Founder, CTO, unnamed in the text captured for this page.
From booths to a Series A
The company's own account of its scale has grown steadily. In January 2022, Eden said more than 100 companies used its cloud PACS. By October 2023 that figure was near 1,000 institutions. A July 2024 release said 1,500 institutions across 17 countries and over 6 million patients treated annually, plus a claim that 75 percent of radiologists in Mexico use the platform. By October 2025, announcing its Series A, Eden said it operated in 18 countries and served more than 2,200 institutions. Eden's current website claims 2,800 plus healthcare systems in 20 countries. None of these counts have been independently audited; they are the company's own figures, rising over time.
On the money side, Sierra Ventures led a $10 million round announced in July 2024 and came back to lead a $22 million Series A announced in October 2025, alongside Liquid 2 Ventures and Grupo Bimbo chief executive Daniel Servitje. Earlier backers named across company materials include Kaszek, Alt Capital's Jack Altman, Khosla Ventures, Dalus Capital, MBX, Meridian Ventures, Hummingbird and ID345, plus Y Combinator itself. SEC filings under the company's legal name, Higia, Inc., show three Form D notices between 2020 and 2024, discussed on Eden's funding profile.
What is proven, and what is still claimed
| Evidence | What the record shows | Source type |
|---|---|---|
| US or Mexican device clearance | No FDA 510(k) or PMA record found under Eden, Higia or Eva as of September 25, 2026. No public COFEPRIS medical device registration for Eden's AI reporting tools was found in the sources reviewed for this page. | Not found |
| AI reporting claims | Eden's website states its AI automatically detects findings in 17,000 monthly studies and reduced dictation by 40 percent. No accuracy figures, validation study or peer reviewed paper was found to support either number. | Company-stated |
| Clinical or research publications | No PubMed indexed papers and no registered clinical trials describing Eden's algorithms were found as of September 25, 2026. | Not found |
| Institution and country counts | Self-reported scale rose from about 100 institutions (Jan 2022) to 1,500 across 17 countries (Jul 2024) to 2,200 across 18 countries (Oct 2025) to 2,800 plus across 20 countries on the current company website. No third party audit of any figure was found. | Company-stated |
| Radiologist adoption in Mexico | Eden and lead investor Sierra Ventures both state that 75 percent of radiologists in Mexico use the platform, first published in July 2024. No independent survey or regulator figure was found to confirm it. | Company and investor stated |
| Named institutional partners | A July 2024 release names Grupo Diagnostico PROA, Laboratorios del Chopo, Grupo Santa Maria, Lapi Laboratorio, Imagenologia Christus Muguerza, and the health secretariats of Chiapas and Chihuahua as users. None independently confirmed the relationship for this page. | Company-stated |
| Public sector reach in Chihuahua | In an October 2023 interview, Eden said it was advancing in the public sector and had impacted over 250,000 patients across several states including Chihuahua. | Interview |
| Reported 2022 round versus SEC filing | Press aggregators reported a roughly $7 million round in June 2022. The Form D covering that period, filed under Higia, Inc. in May 2023, shows $5,403,130 sold from 7 investors, fully subscribed against that offering. | Differs from filing |
Read plainly, Eden has a real and growing commercial footprint in Latin American radiology, backed by institutional venture money and a legal paper trail at the SEC. What has not been demonstrated is the performance of its AI layer against an independent benchmark, or any regulatory clearance for that AI in the United States or Mexico. The scale numbers move only upward and only come from the company itself.
What to watch
- Whether a Form D is filed for the $22 million Series A announced in October 2025. None had appeared under Higia, Inc. as of September 25, 2026.
- Any COFEPRIS or FDA submission covering Eden's AI tools.
- A named, independently confirmed hospital or lab customer.
- Publication of an accuracy or validation study behind Eden Creator or Eden AI.
In their words
“Cancer has been a constant in my life. As someone who will eventually face it, my mission is very personal.”
Julian Rios Cantu, CEO and co-founder, Financial Times, 2022 · Interview
“Running the clinics, we noticed a lack of radiologists: we only have about 7,500 of them [in Mexico] for a population of 120m, and this gets worse outside large cities”
Julian Rios Cantu, Financial Times, 2022 · Interview
“Mexico has a severe shortage of radiologists, with only 4,500 for a population of 120 million.”
Eden, Mexico Business News interview, October 2023 · Interview
“We have been impressed by the depth of their technology, even compared to the leading options available in the US.”
Mark Fernandes, Managing Partner, Sierra Ventures, July 2024 · Investor
“Eden’s journey began with my mother’s battle against breast cancer, exposing the shortcomings in our health system. Motivated by a desire to improve patient care, I gathered a team to create transformative healthcare technology. What started as a personal mission has now treated over 6 million patients, turning a dream into reality.”
Julian Rios Cantu, company release, July 2024 · Company release
“Eden is not only advancing healthcare in LATAM but also challenging the global healthcare ecosystem. Investing in Eden is investing in a healthier future for hundreds of millions of patients.”
Jack Altman, Alt Capital, company release, July 2024 · Company release
“We are building the radiology operating system of reference for Latin America, where deep gaps in access to timely, high-quality diagnostics persist.”
Julian Rios Cantu, LatamList, October 2025 · Company statement
Related companies
Sources
- Public recordForm D, Higia, Inc.
- Public recordForm D, Higia, Inc.
- Public recordForm D, Higia, Inc.
- IndependentMexican platform advances digital diagnostics in Latin America
- IndependentCloud-Based Platform Empowers Radiologists
- IndependentOur Early-Stage Investment in Eden
- IndependentEden raises $22M Series A
- IndependentEden secures $10M to invest in AI for clinical diagnostics
- IndependentEden - 2026 Company Profile & Team
- IndependentJulian Rios, Co-founder and CEO, EVA
- IndependentEden: Building Clinical Superintelligence
- CompanyEden Secures $10M to Transform Radiology in Latin America with AI
- CompanyEden Secures $10M to Transform Radiology in Latin America with AI
- CompanyEden raises $10M to advance AI radiology
- CompanyAbout us
- CompanyEden homepage
- CompanyJulian Rios Cantu profile
Profile researched and written by Healthcare Discovery. Last updated September 29, 2026.
